IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR

Published:2011-01-24 Issue:20 Volume:30 Page:2345-2355
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Rojas A,Liu G,Coleman I,Nelson P S,Zhang M,Dash R,Fisher P B,Plymate S R,Wu J D

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2010605.pdf

Reference46 articles.

1. Al-Shanti N, Saini A, Faulkner SH, Stewart CE . (2008). Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts–potential cross-talk with IGF system. Growth Factors 26: 61–73.

2. Ara T, Declerck YA . (2010). Interleukin-6 in bone metastasis and cancer progression. Eur J Cancer 46: 1223–1231.

3. Bae VL, Jackson-Cook CK, Brothman AR, Maygarden SJ, Ware JL . (1994). Tumorigenicity of SV40T antigen immortalized human prostate epithelial cells: association with decreased epidermal growth factor receptor (EGFR) expression. Int J Cancer 58: 721–729.

4. Bardia A, Platz EA, Yegnasubramanian S, De Marzo AM, Nelson WG . (2009). Anti-inflammatory drugs, antioxidants, and prostate cancer prevention. Curr Opin Pharmacol 9: 419–426.

5. Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A et al. (2004). TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21: 491–501.

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A call for clinical trials in glioblastoma multiforme for interleukin 4, interleukin 6, interleukin 13 and CD40;Neurosurgical Review;2024-09-07

2. Interleukin 6 and cancer resistance in glioblastoma multiforme;Neurosurgical Review;2024-09-05

3. Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression;International Journal of Molecular Sciences;2024-08-17

4. Diosmetin as a promising natural therapeutic agent: In vivo, in vitro mechanisms, and clinical studies;Phytotherapy Research;2024-05-15

5. Role of STAT3 in cancer cell epithelial‑mesenchymal transition (Review);International Journal of Oncology;2024-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3